Table 4.
Correlations with poor outcome
| Yes/Used | No/Not used | p-value | |
|---|---|---|---|
| Anorexia | 9 | 132 | < 0.01b |
| Cyanosis | 8 | 133 | > 0.05 |
| Fever | 47 | 94 | < 0.01 |
| Hypoxia | 3 | 138 | < 0.01b |
| Malaise/Fatigue | 54 | 87 | < 0.01b |
| Cellulitis | 108 | 33 | < 0.05a |
| Edema | 135 | 3 | > 0.05 |
| Erythema | 134 | 7 | > 0.05 |
| Eschar | 97 | 44 | > 0.05 |
| Fasciitis | 9 | 132 | < 0.01b |
| Lymphadenopathy | 36 | 105 | < 0.01b |
| Lymphangitis | 18 | 123 | > 0.05 |
| Pruritus | 31 | 110 | > 0.05 |
| Vesicles | 75 | 66 | > 0.05 |
| Coronary artery disease | 7 | 134 | > 0.05 |
| Ciprofloxacin | 59 | 81 | > 0.05 |
| Levofloxacin | 8 | 133 | > 0.05 |
| Penicillin and penicillin derivates (amoxicillin. ampicillin) | 96 | 45 | > 0.05 |
| Continuous Variables | |||
| Age | > 0.05 | ||
| Gender | > 0.05 | ||
| Elapsing time between earliest possible exposure to start of treatment (days) | > 0.05 | ||
| Elapsing time between the onset of symptoms to start of treatment (days) | > 0.05 | ||
| Leukocytosis | < 0.01b | ||
| C-reactive protein | < 0.05a | ||
| Serum creatinine | < 0.05a | ||
| Type of therapy | < 0.01b | ||
| Duration of antimicrobial therapy (days) | < 0.05a | ||
a
The level of statistically significant: p < 0,05
b
The level of statistically significant: p < 0,01